[go: up one dir, main page]

FR2703251B3 - Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine . - Google Patents

Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .

Info

Publication number
FR2703251B3
FR2703251B3 FR9303787A FR9303787A FR2703251B3 FR 2703251 B3 FR2703251 B3 FR 2703251B3 FR 9303787 A FR9303787 A FR 9303787A FR 9303787 A FR9303787 A FR 9303787A FR 2703251 B3 FR2703251 B3 FR 2703251B3
Authority
FR
France
Prior art keywords
muramyl
cytokine
peptide
association
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9303787A
Other languages
English (en)
Other versions
FR2703251A1 (fr
Inventor
Chedid Louis
Bahr Georges
Lefrancier Pierre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vacsyn SA
Original Assignee
Vacsyn SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9303787A priority Critical patent/FR2703251B3/fr
Application filed by Vacsyn SA filed Critical Vacsyn SA
Priority to JP52072694A priority patent/JP3723206B2/ja
Priority to DE69431620T priority patent/DE69431620T2/de
Priority to AT94910445T priority patent/ATE226828T1/de
Priority to EP94910445A priority patent/EP0689449B1/fr
Priority to PCT/FR1994/000307 priority patent/WO1994021275A1/fr
Priority to AU62856/94A priority patent/AU6285694A/en
Priority to DK94910445T priority patent/DK0689449T3/da
Priority to PT94910445T priority patent/PT689449E/pt
Priority to CA002157758A priority patent/CA2157758A1/fr
Priority to ES94910445T priority patent/ES2187520T3/es
Priority to US08/522,342 priority patent/US5932208A/en
Publication of FR2703251A1 publication Critical patent/FR2703251A1/fr
Application granted granted Critical
Publication of FR2703251B3 publication Critical patent/FR2703251B3/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR9303787A 1993-03-19 1993-03-31 Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine . Expired - Lifetime FR2703251B3 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR9303787A FR2703251B3 (fr) 1993-03-31 1993-03-31 Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .
PT94910445T PT689449E (pt) 1993-03-19 1994-03-21 Composicoes para aplicacao em terapeutica humana caracterizadas pela associacao de um peptido de muramilo a uma citoquina
AT94910445T ATE226828T1 (de) 1993-03-19 1994-03-21 Zusammensetzungen für die anwendung in menschlicher therapie, charakterisiert durch die assoziation eines muramylpeptids mit einem cytokin
EP94910445A EP0689449B1 (fr) 1993-03-19 1994-03-21 Compositions pour l'application en therapeutique humaine, caracterisees par l'association d'un muramyl-peptide a une cytokine
PCT/FR1994/000307 WO1994021275A1 (fr) 1993-03-19 1994-03-21 Compositions pour l'application en therapeutique humaine, caracterisees par l'association d'un muramyl-peptide a une cytokine
AU62856/94A AU6285694A (en) 1993-03-19 1994-03-21 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
JP52072694A JP3723206B2 (ja) 1993-03-19 1994-03-21 ムラミルペプチドとサイトカインとを組み合わせることを特徴とするヒトに用いる治療用組成物
DE69431620T DE69431620T2 (de) 1993-03-19 1994-03-21 Zusammensetzungen für die anwendung in menschlicher therapie, charakterisiert durch die assoziation eines muramylpeptids mit einem cytokin
CA002157758A CA2157758A1 (fr) 1993-03-19 1994-03-21 Compositions pour l'application en therapeutique humaine, caracterisees par l'association d'un muramyl-peptide a une cytokine
ES94910445T ES2187520T3 (es) 1993-03-19 1994-03-21 Composiciones para aplicacion en terapeutica humana, caracterizadas por la asociacion de un muramil-peptido a una citoquina.
US08/522,342 US5932208A (en) 1993-03-19 1994-03-21 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine
DK94910445T DK0689449T3 (da) 1993-03-19 1994-03-21 Præparater til anvendelse i humanterapi, kendetegnet ved kombination af et muramylpeptid med en cytokin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303787A FR2703251B3 (fr) 1993-03-31 1993-03-31 Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .

Publications (2)

Publication Number Publication Date
FR2703251A1 FR2703251A1 (fr) 1994-10-07
FR2703251B3 true FR2703251B3 (fr) 1995-08-04

Family

ID=9445593

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9303787A Expired - Lifetime FR2703251B3 (fr) 1993-03-19 1993-03-31 Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .

Country Status (1)

Country Link
FR (1) FR2703251B3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108136025B (zh) 2015-07-16 2022-09-06 比奥克斯塞尔医疗股份有限公司 一种使用免疫调节治疗癌症的新颖方法

Also Published As

Publication number Publication date
FR2703251A1 (fr) 1994-10-07

Similar Documents

Publication Publication Date Title
FR2705842B3 (fr) Ensemble d'entraînement pour électromobile.
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
EP0847757A4 (fr) Medicament comprenant le gene hgf
NO954694D0 (no) Doseringsform for antidepressiva
FR2676256B1 (fr) Unite d'entrainement pour ventilateur double.
FR2712666B1 (fr) Luminaire pour application médicale.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
CA2192480A1 (fr) Benzopyrannes et leur utilisation en tant qu'agents therapeutiques
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
EP0622873A3 (fr) Mécanisme d'entraînement pour le poinçon.
ITTO930866A0 (it) Procedimento e macchina per la fabbricazione di copertine per libri e simili, e copertine cosi' realizzate.
EP0624632A3 (fr) Liquide d'enregistrement.
FR2703251B3 (fr) Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .
FR2695297B1 (fr) Composition d'agent désinfectant.
FR2702659B1 (fr) Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine.
FR2686251B1 (fr) Composition pour la cicatrisation d'une plaie.
FR2710388B1 (fr) Vanne d'arrêt.
DE69201478D1 (de) Verschliessfeste eutektische Aluminium-Siliziumlegierung.
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
ITTO920793A1 (it) Maturatore di cagliata per provolone e simili.
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
FR2697436B1 (fr) Assouplisseur d'anneaux réglable pour la gymnastique.
ITRM930338A0 (it) Raccoglitore per istruzioni per l'utilizzo di mezzi di organizzazione.
IT8819447A0 (it) Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antinfiammatoria.